The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $11.88

Today's change0.00 0.00%
Updated March 30 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $11.88

Today's change0.00 0.00%
Updated March 30 4:00 PM EDT. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc closed at (U.S.)$11.88.

Over the last five days, shares have lost 3.73% and are down 6.97% for the last year to date. This security has underperformed the S&P 500 by 46.31% during the last year.

Key company metrics

  • Open(U.S.) $11.93
  • Previous close(U.S.) $11.88
  • High(U.S.) $12.05
  • Low(U.S.) $11.73
  • Bid / Ask-- / --
  • YTD % change-6.97%
  • Volume1,661,655
  • Average volume (10-day)2,249,834
  • Average volume (1-month)3,202,683
  • Average volume (3-month)3,419,579
  • 52-week range(U.S.) $11.00 to (U.S.) $18.40
  • Beta0.99
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward26.76×
  • Forward PEG1.15×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.37
Updated March 30 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-4.82%

Allscripts Healthcare Solutions Inc has a net profit margin of -4.82%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.65%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue341345351340
Total other revenue--------
Total revenue341345351340
Gross profit136131140138
Total cost of revenue205214211202
Total operating expense340364360352
Selling / general / administrative85978790
Research & development42465352
Depreciation / amortization9788
Interest expense (income), net operating--------
Unusual expense (income)0020
Other operating expenses, total--------
Operating income1-19-9-12
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-7-26-16-19
Income after tax-2-26-18-21
Income tax, total-4022
Net income-2-26-18-21
Total adjustments to net income--------
Net income before extra. items-2-26-18-21
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-26-18-21
Inc. avail. to common incl. extra. items-2-26-18-21
Diluted net income-2-26-18-21
Dilution adjustment----00
Diluted weighted average shares180180180179
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.14-0.10-0.12
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.01-0.14-0.09-0.12